Roles of long non‑coding RNA SNHG16 in human digestive system cancer (Review)
- Authors:
- Lujie Zhao
- Yuling Kan
- Lu Wang
- Jiquan Pan
- Yun Li
- Haiyan Zhu
- Zhongfa Yang
- Lin Xiao
- Xinhua Fu
- Fujun Peng
- Haipeng Ren
-
Affiliations: School of Basic Medical Sciences, Shandong Second Medical University, Weifang, Shandong 261053, P.R. China, Central Laboratory of Binzhou People's Hospital, Binzhou, Shandong 256600, P.R. China, School of Clinical Medical Sciences, Shandong Second Medical University, Weifang, Shandong 261053, P.R. China, Department of Medical Oncology, Weifang People's Hospital, Weifang, Shandong 261000, P.R. China - Published online on: June 28, 2024 https://doi.org/10.3892/or.2024.8765
- Article Number: 106
-
Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
Assarzadegan N and Montgomery E: What is New in the 2019 World Health Organization (WHO) classification of tumors of the digestive system: Review of selected updates on neuroendocrine neoplasms, appendiceal tumors, and molecular testing. Arch Pathol Lab Med. 145:664–677. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Guo LW, Shi CL, Huang HY, Wang L, Yue XP, Liu SZ, Li J, Su K, Dai M, Sun XB and Shi JF: Economic burden of esophageal cancer in China from 1996 to 2015: A systematic review. Zhonghua Liu Xing Bing Xue Za Zhi. 38:102–109. 2017.(In Chinese). PubMed/NCBI | |
|
Klimeck L, Heisser T, Hoffmeister M and Brenner H: Colorectal cancer: A health and economic problem. Best Pract Res Clin Gastroenterol. 66:1018392023. View Article : Google Scholar : PubMed/NCBI | |
|
Hojman P, Gehl J, Christensen JF and Pedersen BK: Molecular mechanisms linking exercise to cancer prevention and treatment. Cell Metab. 27:10–21. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Xu W, Li B, Xu M, Yang T and Hao X: Traditional Chinese medicine for precancerous lesions of gastric cancer: A review. Biomed Pharmacother. 146:1125422022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, Qiu H, Li C, Cai P and Qi F: The positive role of traditional Chinese medicine as an adjunctive therapy for cancer. Biosci Trends. 15:283–298. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Halbrook CJ, Lyssiotis CA, Pasca di Magliano M and Maitra A: Pancreatic cancer: Advances and challenges. Cell. 186:1729–1754. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Vincent A, Herman J, Schulick R, Hruban RH and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Xie YH, Chen YX and Fang JY: Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther. 5:222020. View Article : Google Scholar : PubMed/NCBI | |
|
Bhan A, Soleimani M and Mandal SS: Long noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Lorenzi L, Avila Cobos F, Decock A, Everaert C, Helsmoortel H, Lefever S, Verboom K, Volders PJ, Speleman F, Vandesompele J and Mestdagh P: Long noncoding RNA expression profiling in cancer: Challenges and opportunities. Genes Chromosomes Cancer. 58:191–199. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Salmena L, Poliseno L, Tay Y, Kats L and Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Dong X, Guo X, Li C, Fan Y, Liu P, Yuan D, Ma X, Wang J, Zheng J, et al: LncRNA-BC069792 suppresses tumor progression by targeting KCNQ4 in breast cancer. Mol Cancer. 22:412023. View Article : Google Scholar : PubMed/NCBI | |
|
Yu M, Ohira M, Li Y, Niizuma H, Oo ML, Zhu Y, Ozaki T, Isogai E, Nakamura Y, Koda T, et al: High expression of ncRAN, a novel non-coding RNA mapped to chromosome 17q25.1, is associated with poor prognosis in neuroblastoma. Int J Oncol. 34:931–938. 2009.PubMed/NCBI | |
|
Ghafouri-Fard S, Khoshbakht T, Taheri M and Shojaei S: A review on the role of small nucleolar RNA host gene 6 long non-coding RNAs in the carcinogenic processes. Front Cell Dev Biol. 9:7416842021. View Article : Google Scholar : PubMed/NCBI | |
|
Gong CY, Tang R, Nan W, Zhou KS and Zhang HH: Role of SNHG16 in human cancer. Clin Chim Acta. 503:175–180. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Yang M and Wei W: SNHG16: A novel long-non coding RNA in human cancers. Onco Targets Ther. 12:11679–11690. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang W, Zhou X, Tang Z, Fu L, Zou S and Tang S: Knockdown of lncRNA SNHG16 attenuates the proliferation and radioresistance of nasopharyngeal carcinoma cells by mediating miR-31-5p/SFN axis. Radiat Res. 199:124–131. 2023.PubMed/NCBI | |
|
Cao X, Xu J and Yue D: LncRNA-SNHG16 predicts poor prognosis and promotes tumor proliferation through epigenetically silencing p21 in bladder cancer. Cancer Gene Ther. 25:10–17. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Yang XS, Wang GX and Luo L: Long non-coding RNA SNHG16 promotes cell growth and metastasis in ovarian cancer. Eur Rev Med Pharmacol Sci. 22:616–622. 2018.PubMed/NCBI | |
|
Li S, Zhang S and Chen J: c-Myc induced upregulation of long non-coding RNA SNHG16 enhances progression and carcinogenesis in oral squamous cell carcinoma. Cancer Gene Ther. 26:400–410. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Sealock T and Sharma S: Smoking Cessation. StatPearls [Internet]. StatPearls Publishing; Treasure Island, FL: 2024 | |
|
Yuan S, Chen J, Ruan X, Sun Y, Zhang K, Wang X, Li X, Gill D, Burgess S, Giovannucci E and Larsson SC: Smoking, alcohol consumption, and 24 gastrointestinal diseases: Mendelian randomization analysis. Elife. 12:e840512023. View Article : Google Scholar : PubMed/NCBI | |
|
GBD 2019 Cancer Risk Factors Collaborators, . The global burden of cancer attributable to risk factors, 2010-19: A systematic analysis for the global burden of disease study 2019. Lancet. 400:563–591. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Marti-Aguado D, Clemente-Sanchez A and Bataller R: Cigarette smoking and liver diseases. J Hepatol. 77:191–205. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Baecker A, Liu X, La Vecchia C and Zhang ZF: Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors. Eur J Cancer Prev. 27:205–212. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Cho WR, Wang CC, Tsai MJ, Lin CC, Yen YH, Chen CH, Kuo YH, Yao CC, Hung CH, Huang PY, et al: Smoking as a risk factor for very late recurrence in surgically resected early-stage primary hepatocellular carcinoma. Clin Med Insights Oncol. 18:117955492412282322024. View Article : Google Scholar : PubMed/NCBI | |
|
Klein AP: Pancreatic cancer epidemiology: Understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol. 18:493–502. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Lynch SM, Vrieling A, Lubin JH, Kraft P, Mendelsohn JB, Hartge P, Canzian F, Steplowski E, Arslan AA, Gross M, et al: Cigarette smoking and pancreatic cancer: A pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol. 170:403–413. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Bosetti C, Lucenteforte E, Silverman DT, Petersen G, Bracci PM, Ji BT, Negri E, Li D, Risch HA, Olson SH, et al: Cigarette smoking and pancreatic cancer: An analysis from the international pancreatic cancer case-control consortium (Panc4). Ann Oncol. 23:1880–1888. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Ghadirian P, Lynch HT and Krewski D: Epidemiology of pancreatic cancer: An overview. Cancer Detect Prev. 27:87–93. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Iodice S, Gandini S, Maisonneuve P and Lowenfels AB: Tobacco and the risk of pancreatic cancer: A review and meta-analysis. Langenbecks Arch Surg. 393:535–545. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Weissman S, Takakura K, Eibl G, Pandol SJ and Saruta M: The diverse involvement of cigarette smoking in pancreatic cancer development and prognosis. Pancreas. 49:612–620. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Li H, Chen X, Hoffmeister M and Brenner H: Associations of smoking with early- and late-onset colorectal cancer. JNCI Cancer Spectr. 7:pkad0042023. View Article : Google Scholar : PubMed/NCBI | |
|
Han GH, Lu KJ, Wang P, Ye J, Ye YY and Huang JX: LncRNA SNHG16 predicts poor prognosis in ESCC and promotes cell proliferation and invasion by regulating Wnt/β-catenin signaling pathway. Eur Rev Med Pharmacol Sci. 22:3795–3803. 2018.PubMed/NCBI | |
|
Han W, Du X, Liu M, Wang J, Sun L and Li Y: Increased expression of long non-coding RNA SNHG16 correlates with tumor progression and poor prognosis in non-small cell lung cancer. Int J Biol Macromol. 121:270–278. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y, Lu Y and Chen Y: Long non-coding RNA SNHG16 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer via sponging miR-200a-3p. Biosci Rep. 39:BSR201824982019. View Article : Google Scholar : PubMed/NCBI | |
|
Gheliji T, Oskooei VK, Ashrafi Hafez A, Taheri M and Ghafouri-Fard S: Evaluation of expression of vitamin D receptor related lncRNAs in lung cancer. Noncoding RNA Res. 5:83–87. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Jiao R, Jiang W, Wei X, Zhang M, Zhao S and Huang G: Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: A meta-analysis. BMC Cancer. 20:6622020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou L, Zhang Y, Jin J and Gu X: Correlation between lncRNA SNHG16 gene polymorphism and its interaction with environmental factors and susceptibility to colorectal cancer. Medicine (Baltimore). 99:e233722020. View Article : Google Scholar : PubMed/NCBI | |
|
Uhlenhopp DJ, Then EO, Sunkara T and Gaduputi V: Epidemiology of esophageal cancer: Update in global trends, etiology and risk factors. Clin J Gastroenterol. 13:1010–1021. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
McGee EE, Jackson SS, Petrick JL, Van Dyke AL, Adami HO, Albanes D, Andreotti G, Beane-Freeman LE, Berrington de Gonzalez A, Buring JE, et al: Smoking, alcohol, and biliary tract cancer risk: A pooling project of 26 prospective studies. J Natl Cancer Inst. 111:1263–1278. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Wood LD, Canto MI, Jaffee EM and Simeone DM: Pancreatic cancer: Pathogenesis, screening, diagnosis, and treatment. Gastroenterology. 163:386–402.e1. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Laszkowska M, Rodriguez S, Kim J and Hur C: Heavy alcohol use is associated with gastric cancer: Analysis of the national health and nutrition examination survey from 1999 to 2010. Am J Gastroenterol. 116:1083–1086. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
McNabb S, Harrison TA, Albanes D, Berndt SI, Brenner H, Caan BJ, Campbell PT, Cao Y, Chang-Claude J, Chan A, et al: Meta-analysis of 16 studies of the association of alcohol with colorectal cancer. Int J Cancer. 146:861–873. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Sheikh M, Roshandel G, McCormack V and Malekzadeh R: Current status and future prospects for esophageal cancer. Cancers (Basel). 15:7652023. View Article : Google Scholar : PubMed/NCBI | |
|
Larsson SC, Carter P, Kar S, Vithayathil M, Mason AM, Michaëlsson K and Burgess S: Smoking, alcohol consumption, and cancer: A mendelian randomisation study in UK Biobank and international genetic consortia participants. PLoS Med. 17:e10031782020. View Article : Google Scholar : PubMed/NCBI | |
|
Dong J and Thrift AP: Alcohol, smoking and risk of oesophago-gastric cancer. Best Pract Res Clin Gastroenterol. 31:509–517. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Friedenreich CM, Ryder-Burbidge C and McNeil J: Physical activity, obesity and sedentary behavior in cancer etiology: Epidemiologic evidence and biologic mechanisms. Mol Oncol. 15:790–800. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Moore SC, Lee IM, Weiderpass E, Campbell PT, Sampson JN, Kitahara CM, Keadle SK, Arem H, Berrington de Gonzalez A, Hartge P, et al: Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults. JAMA Intern Med. 176:816–825. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Su J, Jiang Y, Fan X, Tao R, Wu M, Lu Y, Hua Y, Jin J, Guo Y, Lv J, et al: Association between physical activity and cancer risk among Chinese adults: A 10-year prospective study. Int J Behav Nutr Phys Act. 19:1502022. View Article : Google Scholar : PubMed/NCBI | |
|
Kasvis P and Kilgour RD: Diet and exercise interventions in patients with pancreatic cancer: A scoping review. Pancreas. 50:657–666. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Xie F, You Y, Huang J, Guan C, Chen Z, Fang M, Yao F and Han J: Association between physical activity and digestive-system cancer: An updated systematic review and meta-analysis. J Sport Health Sci. 10:4–13. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Garrett WS: Cancer and the microbiota. Science. 348:80–86. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Nasrollahzadeh D, Malekzadeh R, Ploner A, Shakeri R, Sotoudeh M, Fahimi S, Nasseri-Moghaddam S, Kamangar F, Abnet CC, Winckler B, et al: Variations of gastric corpus microbiota are associated with early esophageal squamous cell carcinoma and squamous dysplasia. Sci Rep. 5:88202015. View Article : Google Scholar : PubMed/NCBI | |
|
Ponvilawan B, Rittiphairoj T, Charoenngam N, Rujirachun P, Wattanachayakul P, Tornsatitkul S and Ungprasert P: Association between chronic hepatitis C virus infection and esophageal cancer: A systematic review and meta-analysis. J Clin Gastroenterol. 56:55–63. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Chidambaranathan-Reghupaty S, Fisher PB and Sarkar D: Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification. Adv Cancer Res. 149:1–61. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Singh AK, Kumar R and Pandey AK: Hepatocellular carcinoma: Causes, mechanism of progression and biomarkers. Curr Chem Genom Transl Med. 12:9–26. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Mitsuhashi K, Nosho K, Sukawa Y, Matsunaga Y, Ito M, Kurihara H, Kanno S, Igarashi H, Naito T, Adachi Y, et al: Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis. Oncotarget. 6:7209–7220. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Fan X, Alekseyenko AV, Wu J, Peters BA, Jacobs EJ, Gapstur SM, Purdue MP, Abnet CC, Stolzenberg-Solomon R, Miller G, et al: Human oral microbiome and prospective risk for pancreatic cancer: A population-based nested case-control study. Gut. 67:120–127. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang YC: Medicinal plant activity on Helicobacter pylori related diseases. World J Gastroenterol. 20:10368–10382. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ailloud F, Didelot X, Woltemate S, Pfaffinger G, Overmann J, Bader RC, Schulz C, Malfertheiner P and Suerbaum S: Within-host evolution of Helicobacter pylori shaped by niche-specific adaptation, intragastric migrations and selective sweeps. Nat Commun. 10:22732019. View Article : Google Scholar : PubMed/NCBI | |
|
Espinoza JL, Matsumoto A, Tanaka H and Matsumura I: Gastric microbiota: An emerging player in Helicobacter pylori-induced gastric malignancies. Cancer Lett. 414:147–152. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Baj J, Korona-Glowniak I, Forma A, Maani A, Sitarz E, Rahnama-Hezavah M, Radzikowska E and Portincasa P: Mechanisms of the epithelial-mesenchymal transition and tumor microenvironment in Helicobacter pylori-induced gastric cancer. Cells. 9:10552020. View Article : Google Scholar : PubMed/NCBI | |
|
Xia R, Zhang B, Wang X and Jia Q: Pathogenic interactions between Helicobacter pylori adhesion protein HopQ and human cell surface adhesion molecules CEACAMs in gastric epithelial cells. Iran J Basic Med Sci. 22:710–715. 2019.PubMed/NCBI | |
|
Roesler BM, Rabelo-Gonçalves EMA and Zeitune JMR: Virulence factors of Helicobacter pylori: A review. Clin Med Insights Gastroenterol. 7:9–17. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Sasaki S, Nishikawa J, Sakai K, Iizasa H, Yoshiyama H, Yanagihara M, Shuto T, Shimokuri K, Kanda T, Suehiro Y, et al: EBV-associated gastric cancer evades T-cell immunity by PD-1/PD-L1 interactions. Gastric Cancer. 22:486–496. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E and Nougayrède JP: Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci USA. 107:11537–11542. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Flemer B, Warren RD, Barrett MP, Cisek K, Das A, Jeffery IB, Hurley E, O'Riordain M, Shanahan F and O'Toole PW: The oral microbiota in colorectal cancer is distinctive and predictive. Gut. 67:1454–1463. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhong JH, Xiang X, Wang YY, Liu X, Qi LN, Luo CP, Wei WE, You XM, Ma L, Xiang BD and Li LQ: The lncRNA SNHG16 affects prognosis in hepatocellular carcinoma by regulating p62 expression. J Cell Physiol. 235:1090–1102. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Lin Q, Zheng H, Xu J, Zhang F and Pan H: LncRNA SNHG16 aggravates tumorigenesis and development of hepatocellular carcinoma by sponging miR-4500 and targeting STAT3. J Cell Biochem. 120:11604–11615. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Chen H, Li M and Huang P: LncRNA SNHG16 promotes hepatocellular carcinoma proliferation, migration and invasion by regulating miR-186 expression. J Cancer. 10:3571–3581. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Ye J, Zhang R, Du X, Chai W and Zhou Q: Long noncoding RNA SNHG16 induces sorafenib resistance in hepatocellular carcinoma cells through sponging miR-140-5p. Onco Targets Ther. 12:415–422. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Hu YL, Feng Y, Chen YY, Liu JZ, Su Y, Li P, Huang H, Mao QS and Xue WJ: SNHG16/miR-605-3p/TRAF6/NF-κB feedback loop regulates hepatocellular carcinoma metastasis. J Cell Mol Med. 24:7637–7651. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Q, Gao P, Li Q, Xu C, Qu K and Zhang J: Long non-coding RNA SNHG16 as a potential biomarker in hepatocellular carcinoma: A meta-analysis. Medicine (Baltimore). 100:e271782021. View Article : Google Scholar : PubMed/NCBI | |
|
Teng Y, Li M, Tao X, Huang Y, Ding X, Xu D, Fan Y and Shen Z: Cryptococcosis inhibits the immune response of dendritic cells through the snhg1-miR-145a-3p-Bcl2 axis. Exp Clin Transplant. 21:441–450. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Sun W, Zhang X, He X, Zhang J, Wang X, Lin W, Wang X and Wu X: Long non-coding RNA SNHG16 silencing inhibits proliferation and inflammation in Mycobacterium tuberculosis-infected macrophages by targeting miR-140-5p expression. Infect Genet Evol. 103:1053252022. View Article : Google Scholar : PubMed/NCBI | |
|
Allen C, Her S and Jaffray DA: Radiotherapy for cancer: Present and future. Adv Drug Deliv Rev. 109:1–2. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Nobel TB, Barbetta A, Hsu M, Tan KS, Pinchinat T, Schlottmann F, Bains MS, Ku GY, Wu AJ, Patti MG, et al: Outcomes of radiation-associated esophageal squamous cell carcinoma: The MSKCC experience. J Gastrointest Surg. 23:11–22. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Thierry-Chef I, Cardis E, Damilakis J, Frija GA, Hierath M and Hoeschen C: Medical applications of ionizing radiation and radiation protection for European patients, population and environment. EPJ Nuclear Sci Technol. 8:442022. View Article : Google Scholar | |
|
Goerlitz DS, Blancato J, Ramesh A, Islam M, Graham GT, Revina V, Kallakury B, Zeck J, Kirillova E and Loffredo CA: Somatic mutation signatures in primary liver tumors of workers exposed to ionizing radiation. Sci Rep. 9:181992019. View Article : Google Scholar : PubMed/NCBI | |
|
Dores GM, Curtis RE, van Leeuwen FE, Stovall M, Hall P, Lynch CF, Smith SA, Weathers RE, Storm HH, Hodgson DC, et al: Pancreatic cancer risk after treatment of Hodgkin lymphoma. Ann Oncol. 25:2073–2079. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yusefi AR, Bagheri Lankarani K, Bastani P, Radinmanesh M and Kavosi Z: Risk factors for gastric cancer: A systematic review. Asian Pac J Cancer Prev. 19:591–603. 2018.PubMed/NCBI | |
|
Kreuzer M, Straif K, Marsh JW, Dufey F, Grosche B, Nosske D and Sogl M: Occupational dust and radiation exposure and mortality from stomach cancer among German uranium miners, 1946–2003. Occup Environ Med. 69:217–223. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Albert JM: Radiation risk from CT: Implications for cancer screening. AJR Am J Roentgenol. 201:W81–W87. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Sun Y, Zhang T, Wu W, Zhao D, Zhang N, Cui Y, Liu Y, Gu J, Lu P, Xue F, et al: Risk factors associated with precancerous lesions of esophageal squamous cell carcinoma: A screening study in a high risk Chinese population. J Cancer. 10:3284–3290. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang L, Wan X, Shi R, Gong P and Si Y: Comparing spatial patterns of 11 common cancers in Mainland China. BMC Public Health. 22:15512022. View Article : Google Scholar : PubMed/NCBI | |
|
Yang CY, Tsai SS and Chiu HF: Nitrate in drinking water and risk of death from pancreatic cancer in Taiwan. J Toxicol Environ Health A. 72:397–401. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Picetti R, Deeney M, Pastorino S, Miller MR, Shah A, Leon DA, Dangour AD and Green R: Nitrate and nitrite contamination in drinking water and cancer risk: A systematic review with meta-analysis. Environ Res. 210:1129882022. View Article : Google Scholar : PubMed/NCBI | |
|
Nasseri Maleki G, Bayati Khatibi M, Khamnian Z, Jalali Z, Dastgiri S and Ghodrati Aroogh H: Association between nitrate concentration in drinking water and rate of colorectal cancer: A case study in northwestern Iran. Int J Environ Health Res. 32:1791–1800. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Lee W, Kim J, Lim SS, Kim Y, Ahn YS and Yoon JH: External airborne-agent exposure increase risk of digestive tract cancer. Sci Rep. 10:86172020. View Article : Google Scholar : PubMed/NCBI | |
|
Tsai SS, Hsu CT and Yang C: Risk of death from liver cancer in relation to long-term exposure to fine particulate air pollution in Taiwan. J Toxicol Environ Health A. 86:135–143. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Pritchett N, Spangler EC, Gray GM, Livinski AA, Sampson JN, Dawsey SM and Jones RR: Exposure to outdoor particulate matter air pollution and risk of gastrointestinal cancers in adults: A systematic review and meta-analysis of epidemiologic evidence. Environ Health Perspect. 130:360012022. View Article : Google Scholar : PubMed/NCBI | |
|
Taheri M, Rad LM, Hussen BM, Nicknafs F, Sayad A and Ghafouri-Fard S: Evaluation of expression of VDR-associated lncRNAs in COVID-19 patients. BMC Infect Dis. 21:5882021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang S, Chen J, Li B, Cai X, Wang K, Tan Z, Zheng Y and Liu Q: Family history of cancer is a prognostic factor for better survival in operable esophageal squamous cell carcinoma: A propensity score matching analysis. Front Oncol. 12:9459372022. View Article : Google Scholar : PubMed/NCBI | |
|
Yang Y, Wu QJ, Xie L, Chow WH, Rothman N, Li HL, Gao YT, Zheng W, Shu XO and Xiang YB: Prospective cohort studies of association between family history of liver cancer and risk of liver cancer. Int J Cancer. 135:1605–1614. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Abe K, Kitago M, Kitagawa Y and Hirasawa A: Hereditary pancreatic cancer. Int J Clin Oncol. 26:1784–1792. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Choi IJ, Kim CG, Lee JY, Kim YI, Kook MC, Park B and Joo J: Family history of gastric cancer and Helicobacter pylori treatment. N Engl J Med. 382:427–436. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Sninsky JA, Shore BM, Lupu GV and Crockett SD: Risk factors for colorectal polyps and cancer. Gastrointest Endosc Clin N Am. 32:195–213. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Chen T, Cheng H, Chen X, Yuan Z, Yang X, Zhuang M, Lu M, Jin L and Ye W: Family history of esophageal cancer increases the risk of esophageal squamous cell carcinoma. Sci Rep. 5:160382015. View Article : Google Scholar : PubMed/NCBI | |
|
Setia N, Clark JW, Duda DG, Hong TS, Kwak EL, Mullen JT and Lauwers GY: Familial gastric cancers. Oncologist. 20:1365–1377. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Chan JA, Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Thomas J, Schaefer P, Whittom R, Hantel A, et al: Association of family history with cancer recurrence and survival among patients with stage III colon cancer. JAMA. 299:2515–2523. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Han MA, Oh MG, Choi IJ, Park SR, Ryu KW, Nam BH, Cho SJ, Kim CG, Lee JH and Kim YW: Association of family history with cancer recurrence and survival in patients with gastric cancer. J Clin Oncol. 30:701–708. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Su Z, Zou GR, Mao YP, OuYang PY, Cao XL, Xie FY and Li Q: Prognostic impact of family history of cancer in Southern Chinese patients with esophageal squamous cell cancer. J Cancer. 10:1349–1357. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Dai WC, Fan ST, Cheung TT, Chok KS, Chan AC, Tsang SH, Poon RT and Lo CM: The impact of family history of hepatocellular carcinoma on its patients' survival. Hepatobiliary Pancreat Dis Int. 11:160–164. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Hamada T, Yuan C, Yurgelun MB, Perez K, Khalaf N, Morales-Oyarvide V, Babic A, Nowak JA, Rubinson DA, Giannakis M, et al: Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk. Br J Cancer. 120:848–854. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Y, Tong Y, Yang C, Gan Y, Sun H, Bi H, Cao S, Yin X and Lu Z: Consumption of hot beverages and foods and the risk of esophageal cancer: A meta-analysis of observational studies. BMC Cancer. 15:4492015. View Article : Google Scholar : PubMed/NCBI | |
|
Keszei AP, Goldbohm RA, Schouten LJ, Jakszyn P and van den Brandt PA: Dietary N-nitroso compounds, endogenous nitrosation, and the risk of esophageal and gastric cancer subtypes in the Netherlands cohort study. Am J Clin Nutr. 97:135–146. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ibiebele TI, Hughes MC, Whiteman DC and Webb PM; Australian Cancer Study, : Dietary patterns and risk of oesophageal cancers: A population-based case-control study. Br J Nutr. 107:1207–1216. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Kim J, Cho YA, Choi WJ and Jeong SH: Gene-diet interactions in gastric cancer risk: A systematic review. World J Gastroenterol. 20:9600–9610. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Cheng YK, Yao SM, Xu YR and Niu RG: Life-style habits in a high-risk area for upper gastrointestinal cancers: A population-based study from Shanxi, China. Asian Pac J Cancer Prev. 17:4301–4306. 2016.PubMed/NCBI | |
|
Berretta M, Lleshi A, Fisichella R, Berretta S, Basile F, Li Volti G, Bolognese A, Biondi A, De Paoli P, Tirelli U and Cappellani A: The role of nutrition in the development of esophageal cancer: What do we know? Front Biosci (Elite Ed). 4:351–357. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Z and Zhang X: Salt taste preference, sodium intake and gastric cancer in China. Asian Pac J Cancer Prev. 12:1207–1210. 2011.PubMed/NCBI | |
|
Thanikachalam K and Khan G: Colorectal cancer and nutrition. Nutrients. 11:1642019. View Article : Google Scholar : PubMed/NCBI | |
|
Song M, Garrett WS and Chan AT: Nutrients, foods, and colorectal cancer prevention. Gastroenterology. 148:1244–1260.e16. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Rosato V, Bosetti C, Levi F, Polesel J, Zucchetto A, Negri E and La Vecchia C: Risk factors for young-onset colorectal cancer. Cancer Causes Control. 24:335–341. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Murata M: Inflammation and cancer. Environ Health Prev Med. 23:502018. View Article : Google Scholar : PubMed/NCBI | |
|
Ohnishi S, Ma N, Thanan R, Pinlaor S, Hammam O, Murata M and Kawanishi S: DNA damage in inflammation-related carcinogenesis and cancer stem cells. Oxid Med Cell Longev. 2013:3870142013. View Article : Google Scholar : PubMed/NCBI | |
|
Wang RH: From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma. World J Gastroenterol. 21:5210–5219. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Ioannou GN: Epidemiology and risk-stratification of NAFLD-associated HCC. J Hepatol. 75:1476–1484. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Powell EE, Wong VW and Rinella M: Non-alcoholic fatty liver disease. Lancet. 397:2212–2224. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Pouwels S, Sakran N, Graham Y, Leal A, Pintar T, Yang W, Kassir R, Singhal R, Mahawar K and Ramnarain D: Non-alcoholic fatty liver disease (NAFLD): A review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord. 22:632022. View Article : Google Scholar : PubMed/NCBI | |
|
Duell EJ, Lucenteforte E, Olson SH, Bracci PM, Li D, Risch HA, Silverman DT, Ji BT, Gallinger S, Holly EA, et al: Pancreatitis and pancreatic cancer risk: A pooled analysis in the international pancreatic cancer case-control consortium (PanC4). Ann Oncol. 23:2964–2970. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Sipponen P and Maaroos HI: Chronic gastritis. Scand J Gastroenterol. 50:657–667. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Tempera PJ, Michael M, Tageldin O and Hasak S: Gastric cancer due to chronic H. pylori infection: What we know and where we are going. Diseases. 10:572022. View Article : Google Scholar : PubMed/NCBI | |
|
Kim J and Lee HK: Potential role of the gut microbiome in colorectal cancer progression. Front Immunol. 12:8076482022. View Article : Google Scholar : PubMed/NCBI | |
|
Xu B, Zhou X, Li X, Liu C and Yang C: Diabetes mellitus carries a risk of esophageal cancer: A meta-analysis. Medicine (Baltimore). 96:e79442017. View Article : Google Scholar : PubMed/NCBI | |
|
Li M, Park JY, Sheikh M, Kayamba V, Rumgay H, Jenab M, Narh CT, Abedi-Ardekani B, Morgan E, de Martel C, et al: Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time. Gut. 72:846–854. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Chari ST, Leibson CL, Rabe KG, Ransom J, de Andrade M and Petersen GM: Probability of pancreatic cancer following diabetes: A population-based study. Gastroenterology. 129:504–511. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Lim JH, Shin CM, Han KD, Lee SW, Jin EH, Choi YJ, Yoon H, Park YS, Kim N and Lee DH: Association between the persistence of obesity and the risk of gastric cancer: A nationwide population-based study. Cancer Res Treat. 54:199–207. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Guo J, Liu C, Pan J and Yang J: Relationship between diabetes and risk of gastric cancer: A systematic review and meta-analysis of cohort studies. Diabetes Res Clin Pract. 187:1098662022. View Article : Google Scholar : PubMed/NCBI | |
|
Soltani G, Poursheikhani A, Yassi M, Hayatbakhsh A, Kerachian M and Kerachian MA: Obesity, diabetes and the risk of colorectal adenoma and cancer. BMC Endocr Disord. 19:1132019. View Article : Google Scholar : PubMed/NCBI | |
|
Plaz Torres MC, Jaffe A, Perry R, Marabotto E, Strazzabosco M and Giannini EG: Diabetes medications and risk of HCC. Hepatology. 76:1880–1897. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Guo Z, Zhang J, Fan L, Liu J, Yu H, Li X and Sun G: Long noncoding RNA (lncRNA) small nucleolar RNA host gene 16 (SNHG16) predicts poor prognosis and sorafenib resistance in hepatocellular carcinoma. Med Sci Monit. 25:2079–2086. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang QJ, Li DZ, Lin BY, Geng L, Yang Z and Zheng SS: SNHG16 promotes hepatocellular carcinoma development via activating ECM receptor interaction pathway. Hepatobiliary Pancreat Dis Int. 21:41–49. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang C, Huang Q and He F: Correlation of small nucleolar RNA host gene 16 with acute respiratory distress syndrome occurrence and prognosis in sepsis patients. J Clin Lab Anal. 36:e245162022. View Article : Google Scholar : PubMed/NCBI | |
|
Sun J, Xin K, Leng C and Ge J: Down-regulation of SNHG16 alleviates the acute lung injury in sepsis rats through miR-128-3p/HMGB3 axis. BMC Pulm Med. 21:1912021. View Article : Google Scholar : PubMed/NCBI | |
|
Xia L, Zhu G, Huang H, He Y and Liu X: LncRNA small nucleolar RNA host gene 16 (SNHG16) silencing protects lipopolysaccharide (LPS)-induced cell injury in human lung fibroblasts WI-38 through acting as miR-141-3p sponge. Biosci Biotechnol Biochem. 85:1077–1087. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou Z, Zhu Y, Gao G and Zhang Y: Long noncoding RNA SNHG16 targets miR-146a-5p/CCL5 to regulate LPS-induced WI-38 cell apoptosis and inflammation in acute pneumonia. Life Sci. 228:189–197. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Xie C, Zhu B, Gu J and Sun M: The correlation of lncRNA SNHG16 with inflammatory cytokines, adhesion molecules, disease severity, and prognosis in acute ischemic stroke patients. J Clin Lab Anal. 36:e244392022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao Y, Wang H, Tang Y, Wang J, Wu X, He Z, He Y and Tang Z: SNHG16/miR-205/HDAC5 is involved in the progression of renal fibrosis. J Biochem Mol Toxicol. 38:e236172024. View Article : Google Scholar : PubMed/NCBI | |
|
Luo J: KRAS mutation in pancreatic cancer. Semin Oncol. 48:10–18. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Mei ZB, Duan CY, Li CB, Cui L and Ogino S: Prognostic role of tumor PIK3CA mutation in colorectal cancer: A systematic review and meta-analysis. Ann Oncol. 27:1836–1848. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Cox AD, Fesik SW, Kimmelman AC, Luo J and Der CJ: Drugging the undruggable RAS: Mission possible? Nat Rev Drug Discov. 13:828–851. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Busuttil RA, Zapparoli GV, Haupt S, Fennell C, Wong SQ, Pang JM, Takeno EA, Mitchell C, Di Costanzo N, Fox S, et al: Role of p53 in the progression of gastric cancer. Oncotarget. 5:12016–12026. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y, Wu J, Li E, Xiao Z, Lei J, Zhou F, Yin X, Hu D, Mao Y, Wu L and Wenjun L: TP53 mutation detected in circulating exosomal DNA is associated with prognosis of patients with hepatocellular carcinoma. Cancer Biol Ther. 23:439–445. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Wang W, Shao F, Yang X, Wang J, Zhu R, Yang Y, Zhao G, Guo D, Sun Y, Wang J, et al: METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N(6)-methyladenosine-dependent YTHDF binding. Nat Commun. 12:38032021. View Article : Google Scholar : PubMed/NCBI | |
|
Zeineldin M and Neufeld KL: Understanding phenotypic variation in rodent models with germline Apc mutations. Cancer Res. 73:2389–2399. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Cui R, Kamatani Y, Takahashi A, Usami M, Hosono N, Kawaguchi T, Tsunoda T, Kamatani N, Kubo M, Nakamura Y and Matsuda K: Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. Gastroenterology. 137:1768–1775. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Ilango S, Paital B, Jayachandran P, Padma PR and Nirmaladevi R: Epigenetic alterations in cancer. Front Biosci (Landmark Ed). 25:1058–1109. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang K, Chen J, Song H and Chen LB: SNHG16/miR-140-5p axis promotes esophagus cancer cell proliferation, migration and EMT formation through regulating ZEB1. Oncotarget. 9:1028–1040. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang L, Liang H, Zhang J, Yang Y, Ling X and Jiang H: Long non-coding RNA SNHG16 facilitates esophageal cancer cell proliferation and self-renewal through the microRNA-802/PTCH1 axis. Curr Med Chem. 29:6084–6099. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Ren L, Fang X, Shrestha SM, Ji Q, Ye H, Liang Y, Liu Y, Feng Y, Dong J and Shi R: LncRNA SNHG16 promotes development of oesophageal squamous cell carcinoma by interacting with EIF4A3 and modulating RhoU mRNA stability. Cell Mol Biol Lett. 27:892022. View Article : Google Scholar : PubMed/NCBI | |
|
Xie X, Xu X, Sun C and Yu Z: Long intergenic noncoding RNA SNHG16 interacts with miR-195 to promote proliferation, invasion and tumorigenesis in hepatocellular carcinoma. Exp Cell Res. 383:1115012019. View Article : Google Scholar : PubMed/NCBI | |
|
Li S, Qi Y, Huang Y, Guo Y, Huang T and Jia L: Exosome-derived SNHG16 sponging miR-4500 activates HUVEC angiogenesis by targeting GALNT1 via PI3K/Akt/mTOR pathway in hepatocellular carcinoma. J Physiol Biochem. 77:667–682. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Li W, Xu W, Song JS, Wu T and Wang WX: LncRNA SNHG16 promotes cell proliferation through miR-302a-3p/FGF19 axis in hepatocellular carcinoma. Neoplasma. 66:397–404. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Li S, Peng F, Ning Y, Jiang P, Peng J, Ding X, Zhang J, Jiang T and Xiang S: SNHG16 as the miRNA let-7b-5p sponge facilitates the G2/M and epithelial-mesenchymal transition by regulating CDC25B and HMGA2 expression in hepatocellular carcinoma. J Cell Biochem. 121:2543–2558. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Jing Z, Ye X, Ma X, Hu X, Yang W, Shi J, Chen G and Gong L: SNGH16 regulates cell autophagy to promote sorafenib resistance through suppressing miR-23b-3p via sponging EGR1 in hepatocellular carcinoma. Cancer Med. 9:4324–4338. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Xu Y, Luan G, Li Z, Liu Z, Qin G and Chu Y: Tumour-derived exosomal lncRNA SNHG16 induces telocytes to promote metastasis of hepatocellular carcinoma via the miR-942-3p/MMP9 axis. Cell Oncol (Dordr). 46:251–264. 2023.PubMed/NCBI | |
|
Zhang J and Lou W: A key mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network linked to diagnosis and prognosis of hepatocellular carcinoma. Front Oncol. 10:3402020. View Article : Google Scholar : PubMed/NCBI | |
|
Chen S, Zhao Z, Wang X, Zhang Q, Lyu L and Tang B: The predictive competing endogenous RNA regulatory networks and potential prognostic and immunological roles of cyclin A2 in pan-cancer analysis. Front Mol Biosci. 9:8095092022. View Article : Google Scholar : PubMed/NCBI | |
|
Shao X, Zhu J, Shi Y, Fang H, Chen J, Zhang Y, Wang J, Jian H, Lan S, Jiang F, et al: Upregulated UBE4B expression correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma. Aging (Albany NY). 14:9632–9646. 2022.PubMed/NCBI | |
|
Lou W, Wang W, Chen J, Wang S and Huang Y: ncRNAs-mediated high expression of SEMA3F correlates with poor prognosis and tumor immune infiltration of hepatocellular carcinoma. Mol Ther Nucleic Acids. 24:845–855. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Xu F, Zha G, Wu Y, Cai W and Ao J: Overexpressing lncRNA SNHG16 inhibited HCC proliferation and chemoresistance by functionally sponging hsa-miR-93. Onco Targets Ther. 11:8855–8863. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Xu H, Miao X, Li X, Chen H, Zhang B and Zhou W: LncRNA SNHG16 contributes to tumor progression via the miR-302b-3p/SLC2A4 axis in pancreatic adenocarcinoma. Cancer Cell Int. 21:512021. View Article : Google Scholar : PubMed/NCBI | |
|
Yu Y, Zou YF, Hong RQ, Chen WJ, Chen L, Chen WQ, Wang HP and Yu Y: Long non-coding RNA SNHG16 decreased SMAD4 to induce gemcitabine resistance in pancreatic cancer via EZH2-mediated epigenetic modification. Kaohsiung J Med Sci. 38:981–991. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Yu Y, Dong JT, He B, Zou YF, Li XS, Xi CH and Yu Y: LncRNA SNHG16 induces the SREBP2 to promote lipogenesis and enhance the progression of pancreatic cancer. Future Oncol. 15:3831–3844. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Ding Y, Gao S, Zheng J and Chen X: Blocking lncRNA-SNHG16 sensitizes gastric cancer cells to 5-Fu through targeting the miR-506-3p-PTBP1-mediated glucose metabolism. Cancer Metab. 10:202022. View Article : Google Scholar : PubMed/NCBI | |
|
Lian D, Amin B, Du D and Yan W: Enhanced expression of the long non-coding RNA SNHG16 contributes to gastric cancer progression and metastasis. Cancer Biomark. 21:151–160. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao JJ, Liu JJ, Zhang YY, Xia Y, Du H, Yan ZQ, Zhou CH, Xia WS, Zellmer L, Liao DJ, et al: SNHG16 lncRNAs are overexpressed and may be oncogenic in human gastric cancer by regulating cell cycle progression. Neoplasma. 69:49–58. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou C, Zhao J, Liu J, Wei S, Xia Y, Xia W, Bi Y, Yan Z and Huang H: LncRNA SNHG16 promotes epithelial-mesenchymal transition via down-regulation of DKK3 in gastric cancer. Cancer Biomark. 26:393–401. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Yang Z, Pu M, Dong X, Yang H, Chang W, Liu T and Zhang X: CTCF-activated SNHG16 facilitates gastrointestinal stromal tumor by targeting miR-128-3p/CASC3 axis. Exp Cell Res. 417:1131312022. View Article : Google Scholar : PubMed/NCBI | |
|
Wang X, Kan J, Han J, Zhang W, Bai L and Wu H: LncRNA SNHG16 functions as an oncogene by sponging MiR-135a and promotes JAK2/STAT3 signal pathway in gastric cancer. J Cancer. 10:1013–1022. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou W, Zhang S, Li HB, Cai Z, Tang S, Chen LX, Lang JY, Chen Z and Chen XL: Development of prognostic indicator based on autophagy-related lncRNA analysis in colon adenocarcinoma. Biomed Res Int. 2020:98079182020. View Article : Google Scholar : PubMed/NCBI | |
|
Chen ZY, Wang XY, Yang YM, Wu MH, Yang L, Jiang DT, Cai H and Peng Y: LncRNA SNHG16 promotes colorectal cancer cell proliferation, migration, and epithelial-mesenchymal transition through miR-124-3p/MCP-1. Gene Ther. 29:193–205. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Tan P, Xu M, Nie J, Qin J, Liu X, Sun H, Wang S and Pan Y: LncRNA SNHG16 promotes colorectal cancer proliferation by regulating ABCB1 expression through sponging miR-214-3p. J Biomed Res. 36:231–241. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
He X, Ma J, Zhang M, Cui J and Yang H: Long non-coding RNA SNHG16 activates USP22 expression to promote colorectal cancer progression by sponging miR-132-3p. Onco Targets Ther. 13:4283–4294. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Ke D and Wang Q, Ke S, Zou L and Wang Q: Long-non coding RNA SNHG16 supports colon cancer cell growth by modulating miR-302a-3p/AKT axis. Pathol Oncol Res. 26:1605–1613. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Huang E, Ma T, Zhou J, Ma N, Yang W, Liu C, Hou Z, Chen S, Zong Z, Zeng B, et al: A novel senescence-associated LncRNA signature predicts the prognosis and tumor microenvironment of patients with colorectal cancer: A bioinformatics analysis. J Gastrointest Oncol. 13:1842–1863. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Duan L, Xia Y, Li C, Lan N and Hou X: Identification of autophagy-related LncRNA to predict the prognosis of colorectal cancer. Front Genet. 13:9069002022. View Article : Google Scholar : PubMed/NCBI | |
|
Christensen LL, True K, Hamilton MP, Nielsen MM, Damas ND, Damgaard CK, Ongen H, Dermitzakis E, Bramsen JB, Pedersen JS, et al: SNHG16 is regulated by the Wnt pathway in colorectal cancer and affects genes involved in lipid metabolism. Mol Oncol. 10:1266–1282. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Xiang Z, Huang G, Wu H, He Q, Yang C, Dou R, Liu Q, Song J, Fang Y, Wang S and Xiong B: SNHG16 upregulation-induced positive feedback loop with YAP1/TEAD1 complex in colorectal cancer cell lines facilitates liver metastasis of colorectal cancer by modulating CTCs epithelial-mesenchymal transition. Int J Biol Sci. 18:5291–5308. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Wu T, Lei MS, Gao XZ, Xiong TG, Yang K, Gong Q, Tang R, Tian YP and Fu XH: lncRNA SNHG16 mediates cell proliferation and apoptosis in cholangiocarcinoma by directly targeting miR-146a-5p/GATA6 axis. Biochem Genet. 59:1311–1325. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, Shih T and Yao JC: Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 3:1335–1342. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
He W, Li Q, Lu Y, Ju D, Gu Y, Zhao K and Dong C: Cancer treatment evolution from traditional methods to stem cells and gene therapy. Curr Gene Ther. 22:368–385. 2022. View Article : Google Scholar : PubMed/NCBI |
